mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.4 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |